Macrogenics Inc (NASDAQ:MGNX) currently has a daily average trading volume of 612.15K but it saw 1556746 shares traded in last market. With a market cap of 98.42M USD, the company’s current market price of $1.56 came falling about -12.85 while comparing to the previous closing price of $1.79. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.54 and as low as $1.75. In the recent trading on the day, stock has struck highest price mark of $1.55 while lowest mark touched by it was $1.79.
Taking a look at 20-day trading activity of Macrogenics Inc (MGNX) gives us an average price of $2.1835, while its current price level is -92.02% below from 52-week high level whereas it is -11.11% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.5872 while that of 200 days or SMA-200 reads an average of $3.4943. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.99% during that period while stretching the period over a month that decreases to 8.05%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 23.67 which implies that the stock is in oversold territory.
Over the week, MGNX’s stock price is moving -28.44% down while it is -38.58% when we observe its performance for the past one month. Year-to-date it is -52.00% down and over the past year, the stock is showing a downside performance of -89.23%.
The company is expected to be releasing its next quarterly report on 2025-Mar-19, for which analysts forecasted an EPS of -0.69 while estimate for next year EPS is -2.89. In next quarter, company is expected to be making quarterly sales of $11.77M as analysts are expecting the sales for current fiscal year at $62.49M and seeing the company making $84.63M in sales next year. Moreover, analysts are in estimates of $9.59M for current-quarter revenue.
Currently, Macrogenics Inc’s total number of outstanding shares is 62.82M with 2.25% of that held by the insiders while 93.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -45.05% and return on equity (ROE) at -49.85%. Stock’s beta reads 2.11. Stock has a price to book (P/B) ratio of 0.84 while price to sale or P/S ratio amounts to 0.66. Its return on asset (ROA) is -23.20% on average.
